Is curing patients a sustainable business model? Apparently not:
While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.
In other words: It may be nice for people when they get cured, but we make less money that way.
https://www.cnbc.com/2018/04/11/goldman-asks-is-curing-patients-a-sustainable-business-model.html
No comments:
Post a Comment